文献速递生殖医学产科

冻融胚胎移植后出生的单胎至成年早期的健康状况:一项芬兰登记研究

Health of singletons born after frozen embryo transfer until early adulthood: a Finnish register study.
PubMed 文献 · Hum Reprod · 2022-01-01

该回顾性登记队列研究比较1995至2006年冻融胚胎移植后单胎(n=1825)与新鲜胚胎移植后单胎(n=2933)及自然受孕单胎(n=31136)至平均18–20年随访的健康状况。冻融胚胎移植与新鲜胚胎移植组在ICD-10各章节诊断频率及住院医疗需求上无显著差异;但与自然受孕组相比,冻融胚胎移植组多项诊断风险升高。

要点

  • 冻融胚胎移植与新鲜胚胎移植后单胎至成年早期健康无显著差异。
  • 与自然受孕相比,冻融胚胎移植组门诊就诊(aHR 1.23)和住院(aHR 1.28)风险升高。
  • 冻融胚胎移植组多种疾病诊断及先天畸形风险较自然受孕组升高。

核心结论

  • 冻融胚胎移植后单胎的健康状况与新鲜胚胎移植后单胎无差异。
  • 冻融胚胎移植与新鲜胚胎移植的比较结果令人安心,而冻融胚胎移植与自然受孕的比较结果需进一步研究。

研究设计与样本

  • 回顾性登记队列研究,比较1995至2006年冻融胚胎移植后单胎(n=1825)、新鲜胚胎移植后单胎(n=2933)及自然受孕单胎(n=31136),平均随访18–20年。
  • 数据来自芬兰医学出生登记、芬兰医疗保健登记(CRHC)及芬兰统计局的死因登记。
  • 对早产、母亲年龄、产次、基于母亲职业的社会经济状况及子代性别进行了调整。

主要发现

  • 冻融胚胎移植组与新鲜胚胎移植组在ICD-10任何章节的诊断频率及描述住院医疗需求的参数上均无显著差异。
  • 与自然受孕组相比,冻融胚胎移植组有门诊就诊的比例更高(93.5% vs 92.2%,aHR 1.23,95% CI 1.17,1.30),有住院的比例更高(48% vs 46.5%,aHR 1.28,95% CI 1.19,1.37)。
  • 与自然受孕组相比,冻融胚胎移植组传染病和寄生虫病诊断风险升高(aHR 1.24;95% CI 1.11,1.38),肿瘤风险升高(aHR 1.68;95% CI 1.48,1.91)。
  • 与自然受孕组相比,冻融胚胎移植组眼及附件、耳或乳突疾病(aHR 1.11;95% CI 1.01,1.21)、呼吸系统疾病(aHR 1.15;95% CI 1.06,1.23)、消化系统疾病(aHR 1.17;95% CI 1.05,1.32)、皮肤或皮下组织疾病(aHR 1.28;95% CI 1.14,1.43)及泌尿生殖系统疾病(aHR 1.27;95% CI 1.11,1.45)诊断风险升高。
  • 与自然受孕组相比,冻融胚胎移植组先天畸形或染色体异常风险升高(aHR 1.31;95% CI 1.14,1.50),症状、体征或异常临床或实验室发现风险升高(aHR 1.25,95% CI 1.16,1.34)。

关键数值与推荐

  • 冻融胚胎移植组与新鲜胚胎移植组在ICD-10各章节诊断频率及住院医疗需求参数上无显著差异。
  • 冻融胚胎移植组 vs 自然受孕组:门诊就诊93.5% vs 92.2%(aHR 1.23,95% CI 1.17,1.30);住院48% vs 46.5%(aHR 1.28,95% CI 1.19,1.37)。
  • 冻融胚胎移植组 vs 自然受孕组:传染病和寄生虫病aHR 1.24(95% CI 1.11,1.38);肿瘤aHR 1.68(95% CI 1.48,1.91)。
  • 冻融胚胎移植组 vs 自然受孕组:眼及附件、耳或乳突疾病aHR 1.11(95% CI 1.01,1.21);呼吸系统疾病aHR 1.15(95% CI 1.06,1.23);消化系统疾病aHR 1.17(95% CI 1.05,1.32);皮肤或皮下组织疾病aHR 1.28(95% CI 1.14,1.43);泌尿生殖系统疾病aHR 1.27(95% CI 1.11,1.45)。
  • 冻融胚胎移植组 vs 自然受孕组:先天畸形或染色体异常aHR 1.31(95% CI 1.14,1.50);症状、体征或异常临床或实验室发现aHR 1.25(95% CI 1.16,1.34)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • CRHC登记仅覆盖医院住院和门诊医疗,不包括在其他地方诊断的较轻病例。
  • 在本研究设置中无法分别研究ART治疗和不孕症的影响。
  • 尽管队列规模合理,但可靠研究罕见结局(如癌症)需要更大的队列。
  • 冻融胚胎移植与自然受孕的比较结果需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is the health of singletons born after frozen embryo transfer (FET) comparable to that of singletons born after fresh embryo transfer (ET) until early adulthood? SUMMARY ANSWER: The health of singletons born after FET does not differ from that of singletons born after fresh ET. WHAT IS KNOWN ALREADY: The differences in perinatal outcomes of children born after FET and fresh ET are well known. FET is associated with an increased risk of large-for-gestational-age but diminished risks of preterm birth (PTB), small-for-gestational-age and decreased perinatal mortality compared to fresh ET. However, knowledge on the long-term health after FET is scarce. STUDY DESIGN, SIZE, DURATION: This retrospective register-based cohort study compares singletons born after FET (n = 1825) between the years 1995 and 2006 to those born after fresh ET (n = 2933) and natural conception (NC, n = 31 136) with a mean follow-up time of 18-20 years. PARTICIPANTS/MATERIALS, SETTING, METHODS: Singletons born after FET were compared to those born after fresh ET and NC regarding the frequencies of diagnoses in the main ICD-10 chapters (International Statistical Classification of Diseases and Related Health Problems, 10th revision), the number of outpatient visits and hospital admissions, and mortality. Adjustments were made for PTB, maternal age, parity, socioeconomic status based on mother's occupation and offspring sex. The study combines data from the Finnish Medical Birth Register, the Finnish Care Register for Health Care (CRHC) and the Cause-of-Death Register at Statistics Finland. The Student's T-test was used for continuous variables, and the Chi-square test was used for categorical variables. Cox regression was used to estimate crude and adjusted hazard ratios (HRs and aHRs, respectively). A general linear model was used to compare the means of outpatient visits, hospital admissions and lengths of hospital stays per person. MAIN RESULTS AND THE ROLE OF CHANCE: No significant differences between the FET and fresh ET groups were found in the frequency of diagnoses in any of the ICD-10 chapters or in the parameters describing the need for hospital care. However, compared to the NC group, higher proportions in the FET group had outpatient visits in the hospital (93.5% vs 92.2%, aHR 1.23, 95% CI 1.17, 1.30) or hospital admissions (48% vs 46.5%, aHR 1.28, 95% CI 1.19, 1.37). Compared to the NC group, the FET group had elevated adjusted risks of diagnoses of infectious and parasitic diseases (aHR 1.24; 95% CI 1.11, 1.38), neoplasms (aHR 1.68; 95% CI 1.48, 1.91), diseases of the eye and adnexa, the ear or mastoid process (aHR 1.11; 95% CI 1.01, 1.21), the respiratory system (aHR 1.15; 95% CI 1.06, 1.23), the digestive system (aHR 1.17; 95% CI 1.05, 1.32), the skin or subcutaneous tissue (aHR 1.28; 95% CI 1.14, 1.43) and the genitourinary system (aHR 1.27; 95% CI 1.11, 1.45), as well as congenital malformations or chromosomal abnormalities (aHR 1.31; 95% CI 1.14, 1.50) and symptoms, signs or abnormal clinical or laboratory findings (aHR 1.25, 95% CI 1.16, 1.34). LIMITATIONS, REASONS FOR CAUTION: Only hospital-based inpatient and outpatient care is covered by the CRHC register, excluding milder cases diagnosed elsewhere. We were not able to study the effect of ART treatments and subfertility separately in our setting. In addition, although our cohort is reasonably sized, even larger cohorts would be needed to reliably study rare outcomes, such as cancer. WIDER IMPLICATIONS OF THE FINDINGS: For many ICD-10 chapters, we present the first published data on the long-term outcome of singletons born after FET. The results on FET versus fresh ET are reassuring, whereas the results on FET versus NC warrant further investigation. STUDY FUNDING/COMPETING INTEREST(S): Finnish government research funding was obtained for this study. Funding was also obtained from the Finnish Medical Society Duodecim, the Päivikki and Sakari Sohlberg Foundation, Orion Research Foundation, Finnish Society of Obstetrics and Gynaecology (research grants to A.M.T.) and Finnish government research funding. The funding sources were not involved in the planning or execution of the study. The authors have no competing interests to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Terho AM, Tiitinen A, Martikainen H, et al. Health of singletons born after frozen embryo transfer until early adulthood: a Finnish register study. Hum Reprod. 2022. PMID: 36166701. doi:10.1093/humrep/deac211

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。